Lorcaserin and CP-809101 reduce motor impulsivity and reinstatement of food seeking behavior in male rats: Implications for understanding the anti-obesity property of 5-HT2C receptor agonists

scientific article published on 30 May 2016

Lorcaserin and CP-809101 reduce motor impulsivity and reinstatement of food seeking behavior in male rats: Implications for understanding the anti-obesity property of 5-HT2C receptor agonists is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00213-016-4329-3
P698PubMed publication ID27241709

P2093author name stringPaul J Fletcher
Wayne E Pratt
Guy A Higgins
Cam MacMillan
Leo B Silenieks
Everett B Altherr
P2860cites workLorcaserin, a 5-HT(2C) receptor agonist, reduces body weight by decreasing energy intake without influencing energy expenditureQ24611940
Obesity and addiction: neurobiological overlapsQ26827446
Inactivation of the nucleus accumbens core or medial shell attenuates reinstatement of sugar-seeking behavior following sugar priming or exposure to food-associated cuesQ28539522
The serotonin 2C receptor agonist Ro-60-0175 attenuates effects of nicotine in the five-choice serial reaction time task and in drug discriminationQ28576908
Serotonin 2C receptor activates a distinct population of arcuate pro-opiomelanocortin neurons via TRPC channelsQ28585910
The debate over dopamine's role in reward: the case for incentive salienceQ29618738
The neuropharmacology of relapse to food seeking: methodology, main findings, and comparison with relapse to drug seekingQ30479808
Varieties of impulsivityQ33767987
Effects of central 5-hydroxytryptamine depletion on sensitivity to delayed and probabilistic reinforcementQ33930154
High trait impulsivity predicts food addiction-like behavior in the ratQ34068948
Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptorsQ34086043
Role of serotonin 5-HT2A and 5-HT2C receptors on brain stimulation reward and the reward-facilitating effect of cocaineQ34122658
New approaches to the pharmacological treatment of obesity: can they break through the efficacy barrier?Q34129885
Area under the curve as a measure of discountingQ34136600
The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistryQ34153836
Impulsivity, compulsivity, and top-down cognitive controlQ34166008
Serotonin and drug reward: focus on 5-HT2C receptorsQ34277384
Effects of lisdexamfetamine in a rat model of binge-eatingQ40295381
Safety and efficacy of lorcaserin: a combined analysis of the BLOOM and BLOSSOM trialsQ41653487
Determination of discount functions in rats with an adjusting-amount procedureQ41878692
The 5-HT₂C receptor agonist, lorcaserin, and the 5-HT₆ receptor antagonist, SB-742457, promote satiety; a microstructural analysis of feeding behaviour.Q41910031
The pharmacology of impulsive behaviour in rats: the effects of drugs on response choice with varying delays of reinforcementQ42551998
Differential effects of dopaminergic manipulations on risky choiceQ43056112
Serotonin 2C receptor agonists and the behavioural satiety sequence in mice.Q43913101
Nucleus accumbens dopamine and mu-opioid receptors modulate the reinstatement of food-seeking behavior by food-associated cuesQ44057923
Activation of central melanocortin pathways by fenfluramineQ44079737
The 5-HT2A receptor antagonist M100,907 attenuates motor and 'impulsive-type' behaviours produced by NMDA receptor antagonismQ44540861
Attentional effects of nicotine and amphetamine in rats at different levels of motivation.Q44573259
Fractionating impulsivity: contrasting effects of central 5-HT depletion on different measures of impulsive behaviorQ44822531
5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletionQ44962619
Effects of systemic and intra-nucleus accumbens 5-HT2C receptor compounds on ventral tegmental area self-stimulation thresholds in rats.Q46230494
Evaluation of chemically diverse 5-HT₂c receptor agonists on behaviours motivated by food and nicotine and on side effect profilesQ46240693
Opposing roles for the nucleus accumbens core and shell in cue-induced reinstatement of food-seeking behavior.Q46596053
The 5-HT(2C) receptor agonist WAY-163909 decreases impulsivity in the 5-choice serial reaction time testQ46811288
A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trialQ46879925
Impulsive choice and impulsive action predict vulnerability to distinct stages of nicotine seeking in ratsQ46990157
Acute nicotine increases both impulsive choice and behavioural disinhibition in ratsQ48141419
Obesity and the four facets of impulsivityQ48216980
Central serotonin depletion impairs both the acquisition and performance of a symmetrically reinforced go/no-go conditional visual discriminationQ48231322
The Serotonin 2C Receptor Agonist Lorcaserin Attenuates Intracranial Self-Stimulation and Blocks the Reward-Enhancing Effects of NicotineQ48276382
Effect of lesions of the ascending 5-hydroxytryptaminergic pathways on choice between delayed reinforcersQ48389666
Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: interactions with dopaminergic mechanismsQ48559213
Serotonin2 receptor agonists and serotonergic anorectic drugs affect rats' performance differently in a five-choice serial reaction time taskQ48853977
Studies to investigate the role of 5-HT(2C) receptors on cocaine- and food-maintained behavior.Q51372657
The 5-HT(1A) receptor agonist 8-OH-DPAT reduces rats' accuracy of attentional performance and enhances impulsive responding in a five-choice serial reaction time task: role of presynaptic 5-HT(1A) receptors.Q52026882
Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task.Q52144163
Similarities in the action of Ro 60-0175, a 5-HT2C receptor agonist, and d-fenfluramine on feeding patterns in the ratQ60054744
Reduced satiating effect of d -fenfluramine in serotonin 5-HT 2C receptor mutant miceQ60054745
The effects of d -amphetamine, chlordiazepoxide, α-flupenthixol and behavioural manipulations on choice of signalled and unsignalled delayed reinforcement in ratsQ60632122
The mysterious motivational functions of mesolimbic dopamine.Q34310894
Serotonin (5-HT) drugs: effects on appetite expression and use for the treatment of obesityQ34404395
Role of serotonin(2C) receptors in the control of brain dopaminergic functionQ34558814
CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activityQ34562888
Opposing effects of 5-HT(2A) and 5-HT(2C) receptor antagonists in the rat and mouse on premature responding in the five-choice serial reaction time testQ34659207
Multicenter, placebo-controlled trial of lorcaserin for weight managementQ34660152
Reward mechanisms in obesity: new insights and future directionsQ34674976
Discovery and structure-activity relationship of (1R)-8-chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine (Lorcaserin), a selective serotonin 5-HT2C receptor agonist for the treatment of obesityQ34728055
Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterizationQ34746665
Selective serotonin 5-HT(2C) receptor activation suppresses the reinforcing efficacy of cocaine and sucrose but differentially affects the incentive-salience value of cocaine- vs. sucrose-associated cuesQ35046675
Characterization of the 5-HT2C receptor agonist lorcaserin on efficacy and safety measures in a rat model of diet-induced obesityQ35049574
Fine-tuning serotonin2c receptor function in the brain: molecular and functional implicationsQ35072763
Feeding and reward: perspectives from three rat models of binge eatingQ35093247
Effects of the combination of wheel running and atomoxetine on cue- and cocaine-primed reinstatement in rats selected for high or low impulsivityQ35117860
The study of food addiction using animal models of binge eatingQ35163002
Lorcaserin, a 5-HT2C agonist, decreases nicotine self-administration in female ratsQ35188133
The utility of rat models of impulsivity in developing pharmacotherapies for impulse control disordersQ35589965
Metabolic and hedonic drives in the neural control of appetite: who is the boss?Q35663456
The 5-HT2C receptor agonist lorcaserin reduces nicotine self-administration, discrimination, and reinstatement: relationship to feeding behavior and impulse controlQ35837700
Effect of fenfluramine on reinstatement of food seeking in female and male rats: implications for the predictive validity of the reinstatement modelQ35868906
Choice impulsivity: Definitions, measurement issues, and clinical implications.Q35951113
How can drug addiction help us understand obesity?Q36108706
Corticostriatal-hypothalamic circuitry and food motivation: integration of energy, action and rewardQ36313629
Directly Observable Behavioral Effects of Lorcaserin in RatsQ36316458
Serotonin 5-HT2C receptor agonist promotes hypophagia via downstream activation of melanocortin 4 receptorsQ36509808
The use of the reinstatement model to study relapse to palatable food seeking during dietingQ37203397
Systemic treatment with D-fenfluramine, but not sibutramine, blocks cue-induced reinstatement of food-seeking behavior in the rat.Q37366803
Effects of amphetamine and methylphenidate on delay discounting in rats: interactions with order of delay presentation.Q37424552
Principles of motivation revealed by the diverse functions of neuropharmacological and neuroanatomical substrates underlying feeding behaviorQ37543156
Parallel, redundant circuit organization for homeostatic control of feeding behaviorQ37675451
New drug targets for the treatment of obesity.Q37886661
What is the prognosis for new centrally-acting anti-obesity drugs?Q37982154
The neurobiological underpinnings of obesity and binge eating: a rationale for adopting the food addiction modelQ38055594
Food-related impulsivity in obesity and binge eating disorder--a systematic review.Q38075166
The role of impulsivity in relapse vulnerability.Q38086664
Update on obesity pharmacotherapyQ38196951
5-hydroxytryptamine medications for the treatment of obesityQ38449992
P433issue14
P921main subjectobesityQ12174
P1104number of pages16
P304page(s)2841-2856
P577publication date2016-05-30
P1433published inPsychopharmacologyQ1422802
P1476titleLorcaserin and CP-809101 reduce motor impulsivity and reinstatement of food seeking behavior in male rats: Implications for understanding the anti-obesity property of 5-HT2C receptor agonists
P478volume233

Reverse relations

cites work (P2860)
Q36291168Aggressive clinical approach to obesity improves metabolic and clinical outcomes and can prevent bariatric surgery: a single center experience
Q33710789Behavioral Effects of a Novel Benzofuranyl-Piperazine Serotonin-2C Receptor Agonist Suggest a Potential Therapeutic Application in the Treatment of Obsessive-Compulsive Disorder
Q50227324Choice between delayed food and immediate opioids in rats: treatment effects and individual differences
Q92932843Hypophagia induced by hindbrain serotonin is mediated through central GLP-1 signaling and involves 5-HT2C and 5-HT3 receptor activation
Q97883048Lorcaserin Alters Serotonin and Noradrenaline Tissue Content and Their Interaction With Dopamine in the Rat Brain
Q50046451Neural circuits of eating behaviour: Opportunities for therapeutic development.
Q38924615Neurotransmitters: The Critical Modulators Regulating Gut-Brain Axis.
Q38664308Pharmacotherapies for decreasing maladaptive choice in drug addiction: Targeting the behavior and the drug
Q47588598Role of impulsivity and reward in the anti-obesity actions of 5-HT2C receptor agonists
Q89977069Serotonin in Animal Cognition and Behavior
Q37635780Serotonin receptors in depression: from A to B.

Search more.